| Biological Information | |
|---|---|
| Background Information: | L-α-Lysophosphatidylinositol (LPI) is an endogenous phospholipid and endocannabinoid neurotransmitter. This version is derived from soy. LPI is a novel ligand for the G protein-coupled receptor 55 (GPR55), for which it acts as an agonist. Also thought to be a promoter of RhoA-dependent calcium signaling, and an NFAT activator in embryonic kidney 293 cells. Provided as 1 mg of dry powder. |
| Target Name: | Lysophosphatidylinositol |
| Usage | |
| Product Type: | Control Ligands & Inhibitors |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
LPI (soy), L-a-Lysophosphatidylinositol
LPI (soy), L-a-Lysophosphatidylinositol is an agonist for GPR55. This product is provided as 1 mg of dry powder.
Datasheets
92-1120 Datasheet
View Document